Changes are coming to our lives and world that may rival the industrial and internet revolutions. Jeremy Schwartz and Kara Marciscano discuss the BioRevolution already underway and identify the range of business sectors we believe are best positioned to benefit.
The history of cap weighting may surprise investors. Jeff Weniger explains why WisdomTree chooses to weight by fundamentals.
The long-anticipated reversal in favor for lower-multiple value stocks finally took hold last fall. Matt Wagner explains why investors who believe there’s more room to run for value should consider a higher-quality value basket.
The bond sell-off earlier this year has led to high levels of interest rate sensitivity in the stock market. Jeff Weniger makes the case for equity investors to allocate toward value stocks in a rising interest rate environment.
Value investing is in the spotlight, but not all value strategies are created equal. Kara Marciscano dives into how various value factors have performed over recent and longer-term periods.
We believe value and dividend payers still have room to run following historical outperformance to start the year. Against this backdrop, Matt Wagner explains why investors should consider allocating toward higher-quality dividend payers.
Inflation uncertainty has been lurking for several months. Matt Wagner explains why equity income may be an attractive inflation hedge for investors with a greater risk tolerance or longer time horizons.
